Minimal change in HSV-2 seroreactivity: a cross-sectional Swedish population study

Maria K Jonsson1, Michael Levi, Ulla Rudén

  • 1Department of Virology, Swedish Institute for Infectious Disease Control, and Microbiology and Tumour Biology Centre, Karolinska Institute, Stockholm, Sweden. maria.jonsson@student.uib.no

Summary

Herpes simplex virus type 2 (HSV-2) antibody prevalence remained stable in Swedish adults between 1990/91 and 1996/97. Studies found no significant increase in HSV-2 seroprevalence, despite rising HSV-1 infections.